Baum Jason 4
4 · LEAP THERAPEUTICS, INC. · Filed Oct 4, 2024
Insider Transaction Report
Form 4
Baum Jason
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2024-10-02+85,000→ 85,000 totalExercise: $2.45Exp: 2034-10-02→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of October 2, 2024.